Breast cancer is a complex and heterogeneous group of diseases in terms of occurrence,
impact, therapeutic response, and clinical outcomes. It is the most commonly occurring …

Cancer-related cognitive impairment (CRCI) has increasingly been identified over the last
two decades in non-CNS system cancer patients. Across Europe, researchers have …

Background Inflammation is associated with cognitive functioning and dementia in older
adults, but whether inflammation is related to cognitive functioning in youth and whether …

Background Besides their development as additional adjuvant treatments, CDK4/6 inhibitors
combined with endocrine therapy could represent less toxic alternatives to chemotherapy in …

Objective: Oncological care affects the body strongly, even some years after therapies. Body
image, as the mental representation of one's own body, is particularly affected by breast …

Background Cognitive difficulties have been described after chemotherapy for breast
cancer, but there is no standard of care to improve cognitive outcomes in these patients. This …

Purpose Post-mastectomy pain syndrome is a common yet debilitating neuropathic
complication after breast cancer procedures, resulting in significantly reduced quality of life …

Background Cancer-related cognitive decline is a serious problem in long-term survival but
no pivotal study has investigated whether checkpoint inhibitors (ICI) may be associated with …

Chemotherapy-related cognitive impairment (CRCI) is a common adverse effect of treatment
and is characterized by deficits involving multiple cognitive domains including memory …

Background Insomnia and cognitive impairment are both common conditions experienced
by people diagnosed with cancer. Individually, these conditions have negative impacts on …